The ‘If Trump Loses, He Was Stabbed in the Back’

New Post Public Reply Private Reply Replies (1) Message Board

Oct 11, 2016 at 12:08 PM

Quote:

The ‘If Trump Loses, He Was Stabbed in the Back’ Narrative Has Begun

By Hrafnkell Haraldsson on Tue, Oct 11th, 2016 at 9:31 am

"Just know that if the party abandons Donald Trump 30 days before the election, the narrative will be he lost because he got stabbed in the back."

Donald Trump could not possibly lose because his message was toxic. So the Republican Party has resurrected the old myth explaining Germany’s defeat in the First World War: the stab in the back. Such lies are always more palatable and comforting than the truth.

Steve Doocy is the spreader of today’s false gospel, courtesy of Fox News’ Fox & Friends. According to Doocy, Trump is “a unique character,” but he’s the GOP’s unique character and “she’s a lot worse.” It’s a thin thread, but it’s all die-hard Trump supporters have left.

Watch the Fox & Friends co-host do what they do best, and talk themselves into a comfortable lie, courtesy of Media Matters for America:

STEVE DOOCY: Nonetheless, as we just heard from John Roberts what’s going on with Paul Ryan yesterday and talking to his caucus, he’s still endorsing Donald Trump, but won’t campaign with or defend Donald Trump, you know which is curious the message —

BRIAN KILMEADE: Steve he’s not endorsing him, he’s going to vote for him

AINSLEY EARHARDT: He did endorse him and he didn’t walk it back.

DOOCY: He’s still endorsing, he won’t campaign or defend Trump. And he said for the members of Congress, it’s OK for them to do the same. It’s interesting because all along the message has been from Republicans, establishment Republicans, and Donald Trump is not an establishment Republican, but nonetheless, the establishment has said, look, he’s not perfect, but he’s our candidate and she’s a lot worse. Remember, we’ve got to control who picks whom for the Supreme Court. So has something changed?

Just know that if the party abandons Donald Trump 30 days before the election, the narrative will be he lost because he got stabbed in the back.

EARHARDT: And a lot of Republicans are saying like what you were saying. You have to think about the Supreme Court. There can be four justices that are up.

DOOCY: Right, and as so many Republicans have said, he’s better than her. So what changed if anything changed, or isn’t he still the guy?

KILMEADE: Steve, that is a theory. You could say that well if the Republicans didn’t jump ship. But you could also say that Donald Trump did a series of things that were irrational that caused the Republicans to jump ship

EARHARDT: Right, right. (Jeebus, what did they slip into their coffee right there?! )

DOOCY: Look, he’s a unique character, no doubt about it. But he’s the guy who won.

The Trump campaign has hit a point of diminishing returns. For awhile, Trump kept his campaign going on sheer force of hate, but his words and actions have now made his message so toxic that even Republicans who previously supported him are dropping away.

Trump isn’t being stabbed in the back. He is experiencing cause and effect. Even if people disagree with Hillary Clinton’s policy positions, she is clearly the only sane candidate remaining in the race. Republicans recognize this.

The GOP has been doubling down on their hate with every lost election, thinking more of the same will somehow have a different effect. It won’t.

Easy as it is for them to slip into this pre-election excuse making, if Trump loses, it will be because he because he deserved to lose; because enough Americans voted their conscience and found Donald Trump wanting.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Harbour BioMed Joins Stock Connect, Boosts Investor Access

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

KuCoin's KCUSD Tackles Stablecoin Idle Capital Problem

KuCoin's Bold Move with KCUSD Folks, the cat's outta the bag with KuCoin's latest maneuver—introducing KCUSD. At first glance, it seems like they're just introducing another fancy stablecoin product, but peel the onion and there's more to it. We're talking about shaking up how stablecoins sit tight doing nada in the crypto world. KCUSD is out to make those idle balances...

Yas Island's Bold Move: Expanding With Potter Magic

Potter Magic Takes Over Warner Bros. World Abu Dhabi Call it a stroke of wizardry or plain savvy business sense, Miral and Warner Bros. Discovery Global Experiences are betting large on Harry Potter with a trio of themed lands at Warner Bros. World Abu Dhabi. Brace yourselves, because this ain't your mother's theme park nostalgia—this is about breathing new life into a...

Supernova SPAC Lawsuit: Settlement Proposed, $3M on Table

Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...

Global Movement Urges Dr. Hak Ja Han's Release

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

AB SKF to Hold EGM, Spin Off Automotive Assets

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

Lyon Biennale 2026: Art, Dreams, and Lyon's Magic

Unveiling the Art Spectacle in Lyon Alright, buckle up folks, because the 18th Lyon Biennale – Contemporary Art is about to take the stage in grand fashion. Starting on the 19th of September, this art fiesta is not just any exhibit; it's an eleven-venue citywide takeover that runs until the 13th of December, and it is poised to shake up the art scene like a good splash...

EQT Wraps Up Share Buyback with 4.3M Shares Repurchased

EQT's Bold Buyback: Crunching the Numbers Alright, let's peel back the curtain on EQT's latest maneuver—finishing up their share buyback program, all neat and tidy for 2026. They nailed down 707,203 of their own shares just in the first week of September, part of a grand total of 4,368,899 snatched up in the entire effort. That's a whopping SEK 1.448 billion invested in...

Fosun Pharma Hits the Buyback Button: What's Next?

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Stem Cell Market Set for Major Gains to 2031

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...